跳至主要内容
临床试验/NCT03604874
NCT03604874已完成4 期

High Dose Versus Low Dose Oxytocin for Augmentation of Delayed Labour in Obese Women: A Randomized Clinical Trial

Assiut University1 个研究点 分布在 1 个国家目标入组 202 人开始时间: 2018年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
202
试验地点
1
主要终点
The mean duration from oxytocin augmentation initiation to delivery

研究概览

简要总结

Obesity is one of the biggest public health problems of the 21st century as it increases the risk of many co-morbid medical conditions. Obesity in pregnancy places women at higher risk of obstetrical complications during pregnancy, delivery and puerperium. Obesity is a risk factor for cesarean delivery, failed induction of labor and labor dystocia, and prolonged labor curves especially among women with class III obesity.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Care Provider)

入排标准

性别
Female
接受健康志愿者

入选标准

  • Spontaneous onset of labor.
  • Body mass index ≥ 30 kg/m
  • Gestational age ≥ 37 weeks.
  • Singleton pregnancy.
  • Cephalic presentation.
  • Reassuring fetal heart rate monitoring.
  • Inefficient uterine contractions during active labor
  • Women who will accept to participate in the study.

排除标准

  • Non-reassuring fetal assessment at the time of recruitment.
  • Women received cervical ripening agents.
  • Any patients contraindicated for vaginal delivery.
  • Multiple gestations.
  • Malpresentation.
  • Previous cesarean delivery.
  • Patients with cardiac diseases, pre-eclampsia or any other medical disorders.
  • Fetal demise.
  • Intrauterine growth restriction.
  • Estimated fetal weight ≥ 5000 grams.
  • Pre-labor rupture of membranes > 24 hours.

研究组 & 干预措施

low dose oxytocin

Active Comparator

patients will receive intravenous infusion of 5 Units of oxytocin/500 mL lactated ringer solution. Starting rate will be 2 mU/min, incrementally increase by 2 mU/min every 30 minutes until achievement of adequate uterine contractions.

干预措施: Oxytocin (Drug)

high dose oxytocin

Experimental

patients will receive intravenous infusion of 5 Units of oxytocin/500 mL lactated ringer solution. Starting rate will be 4 mU/min, incrementally increase by 4 mU/min every 30 minutes until achievement of adequate uterine contractions

干预措施: Oxytocin (Drug)

结局指标

主要结局

The mean duration from oxytocin augmentation initiation to delivery

时间窗: 12 hours

the calculated time between oxytocin infusion till delivery

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohamed Abbas

Principal investigator

Assiut University

研究点 (1)

Loading locations...

相似试验